Monday 26 October 2020 - A world-first double-blind clinical trial, will investigate if a powerful drug used to treat nausea in...

Parkinson's UK has invested an additional £1 million in NRG Therapeutics Ltd’s mitochondrial drug development programme.

This week key colleagues from Parkinson's UK met with the UK Medicines and Healthcare products Regulatory Agency (MHRA) along with...

Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may hav

Parkinson’s UK is pleased to announce the release of the next tranche of funding to continue our collaboration with NRG Therapeutics Ltd...

Parkinson's Foundation grants £200,000 to Parkinson's UK to invest in the Parkinson's Virtual Biotech. Each year, Parkinson's UK, their...